These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 26971034)

  • 21. Melatonin reverses the expression of morphine-induced conditioned place preference through its receptors within central nervous system in mice.
    Han J; Xu Y; Yu CX; Shen J; Wei YM
    Eur J Pharmacol; 2008 Oct; 594(1-3):125-31. PubMed ID: 18706407
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibitory effects of forced swim stress and corticosterone on the acquisition but not expression of morphine-induced conditioned place preference: involvement of glucocorticoid receptor in the basolateral amygdala.
    Attarzadeh-Yazdi G; Karimi S; Azizi P; Yazdi-Ravandi S; Hesam S; Haghparast A
    Behav Brain Res; 2013 Sep; 252():339-46. PubMed ID: 23800381
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modulation of morphine antinociceptive tolerance and physical dependence by co-administration of simvastatin.
    Mansouri MT; Khodayar MJ; Tabatabaee A; Ghorbanzadeh B; Naghizadeh B
    Pharmacol Biochem Behav; 2015 Oct; 137():38-43. PubMed ID: 26255154
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oxytocin mediates the inhibitory action of acute lithium on the morphine dependence in rats.
    You ZD; Li JH; Song CY; Lu CL; He C
    Neurosci Res; 2001 Oct; 41(2):143-50. PubMed ID: 11591442
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Repeated administration of dopaminergic agents in the nucleus accumbens and morphine-induced place preference.
    Zarrindast MR; Azami BN; Rostami P; Rezayof A
    Behav Brain Res; 2006 May; 169(2):248-55. PubMed ID: 16472879
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential effects of aprepitant, a clinically used neurokinin-1 receptor antagonist on the expression of conditioned psychostimulant versus opioid reward.
    Mannangatti P; Sundaramurthy S; Ramamoorthy S; Jayanthi LD
    Psychopharmacology (Berl); 2017 Feb; 234(4):695-705. PubMed ID: 28013351
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acquisition and expression of ethanol-induced conditioned place preference in mice is inhibited by naloxone.
    Wróbel M
    Pharmacol Rep; 2011; 63(1):79-85. PubMed ID: 21441614
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Involvement of dopamine D2 receptors of the central amygdala on the acquisition and expression of morphine-induced place preference in rat.
    Rezayof A; Zarrindast MR; Sahraei H; Haeri-Rohani AH
    Pharmacol Biochem Behav; 2002 Dec; 74(1):187-97. PubMed ID: 12376167
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of dorsal hippocampal orexin-2 receptor antagonism on the acquisition, expression, and extinction of morphine-induced place preference in rats.
    Sadeghi B; Ezzatpanah S; Haghparast A
    Psychopharmacology (Berl); 2016 Jun; 233(12):2329-41. PubMed ID: 27048158
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of imipramine on the expression and acquisition of morphine-induced conditioned place preference in mice.
    Zarrindast MR; Bahreini T; Adl M
    Pharmacol Biochem Behav; 2002 Nov; 73(4):941-9. PubMed ID: 12213541
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Morphine-induced place preference: involvement of the central amygdala NMDA receptors.
    Rezayof A; Golhasani-Keshtan F; Haeri-Rohani A; Zarrindast MR
    Brain Res; 2007 Feb; 1133(1):34-41. PubMed ID: 17184750
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Extracellular signal-regulated kinase (ERK) inhibition does not prevent the development or expression of tolerance to and dependence on morphine in the mouse.
    Moulédous L; Díaz MF; Gutstein HB
    Pharmacol Biochem Behav; 2007 Nov; 88(1):39-46. PubMed ID: 17764731
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Involvement of nitric oxide system in enhancement of morphine-induced conditioned place preference by agmatine in male mice.
    Khoshnoodi MA; Motiei-Langroudi R; Tahsili-Fahadan P; Yahyavi-Firouz-Abadi N; Ghahremani MH; Dehpour AR
    Neurosci Lett; 2006 May; 399(3):234-9. PubMed ID: 16490306
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Blockade of Cannabinoid CB1 receptor attenuates the acquisition of morphine-induced conditioned place preference along with a downregulation of ERK, CREB phosphorylation, and BDNF expression in the nucleus accumbens and hippocampus.
    Zhang J; Wang N; Chen B; Wang Y; He J; Cai X; Zhang H; Wei S; Li S
    Neurosci Lett; 2016 Sep; 630():70-76. PubMed ID: 27461790
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Conditioned rewarding effects of morphine and methadone in mice pre-exposed to cocaine.
    Hołuj M; Bisaga A; Popik P
    Pharmacol Rep; 2013; 65(5):1176-84. PubMed ID: 24399713
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bulleyaconitine A Inhibits Morphine-Induced Withdrawal Symptoms, Conditioned Place Preference, and Locomotor Sensitization Via Microglial Dynorphin A Expression.
    Zhao MJ; Wang MY; Ma L; Ahmad KA; Wang YX
    Front Pharmacol; 2021; 12():620926. PubMed ID: 33716748
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Naloxone enhances the expression of morphine-induced conditioned place preference.
    Neisewander JL; Pierce RC; Bardo MT
    Psychopharmacology (Berl); 1990; 100(2):201-5. PubMed ID: 2305008
    [TBL] [Abstract][Full Text] [Related]  

  • 38. M
    Wu J; Li X; Zhou P; Li X
    Eur J Pharmacol; 2020 Sep; 882():173274. PubMed ID: 32534071
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effects of exogenous CCK-8 on the acquisition and expression of morphine-induced CPP.
    Wen D; Cong B; Ma C; Yang S; Yu H; Ni Z; Li S
    Neurosci Lett; 2012 Feb; 510(1):24-8. PubMed ID: 22245440
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endogenous cannabinoid, 2-arachidonoylglycerol, attenuates naloxone-precipitated withdrawal signs in morphine-dependent mice.
    Yamaguchi T; Hagiwara Y; Tanaka H; Sugiura T; Waku K; Shoyama Y; Watanabe S; Yamamoto T
    Brain Res; 2001 Aug; 909(1-2):121-6. PubMed ID: 11478928
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.